coramibio logo

Corami Therapeutics

Corami Therapeutics is an early-stage startup developing a combination platform drug delivery device and therapeutic hydrogels
2016
Gaussan, France

Innovation

Industry Problem

Current medications to treat atrial fibrillation have low success rates and potentially toxic side effects

R&D Focus

Drug delivery device and therapeutic hydrogels

Innovative Solution

Corami’s key innovation is a catheter device that allows therapeutic gels to be placed directly on the surface of the heart

Solution Effectiveness

Corami’s targeted delivery means the heart receives a sustained gel dose while minimizing side effects caused by a broader dosing approach

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

$141.8K

Last Funding Amount

$41.9K

Last Funding Date

October 3, 2017

Startup Stage

Early-Stage

People

Founders

CEO

Products

Demo Product or Complete Product?

Development